Skip to main content
. Author manuscript; available in PMC: 2022 Nov 23.
Published in final edited form as: Clin Gastroenterol Hepatol. 2019 Dec 13;18(8):1842–1850.e6. doi: 10.1016/j.cgh.2019.11.060

Table 3.

Diagnostic Accuracy of CAP for the Detection of Hepatic Steatosis

AUROC (95% CI) Cutoff (dB/m) Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Detection of MRI-PDFF ≥5%
CAP XL probe
Threshold for 90% sensitivity 0.836 (0.72–0.89) 261.4 90 50.0 79.5 72.7
Optimal threshold 294 75.0 78.1 87.9 59.5
Threshold for 90% specificity 316 58.8 90 90.9 50.0
CAP XL probe
Threshold for 90% sensitivity 0.858 (0.73–0.90) 281.4 90 65.6 84.9 77.8
Optimal threshold 307 73.5 75.0 86.2 57.1
Threshold for 90% specificity 323.8 61.8 90 91.3 51.9
Detection of MRI-PDFF ≥10%
CAP M probe
Threshold for 90% sensitivity 0.886 (0.80–0.94) 293.6 90 70.8 73.3 69.2
Optimal threshold 311 79.2 84.6 82.6 81.5
Threshold for 90% specificity 326.8 58.3 90 82.4 69.7
CAP XL probe
Threshold for 90% sensitivity 0.93 (0.86–0.97) 314.2 90 82.7 83.0 91.5
Optimal threshold 322 83.3 86.5 85.1 84.9
Threshold for 90% specificity 323.8 83.3 90 87.0 85.2

AUROC, area under the receiver-operating characteristic curve; CAP, controlled attenuation parameter; CI, confidence of interval; MRI-PDFF, magnetic resonance imaging–proton density fat fraction; NPV, negative predictive value; PPV, positive predictive value.